✦ LIBER ✦

Erratum: HIV-cell fusion: The viral mousetrap

✍ Scribed by Mitchell, Allison

Book ID: 109796014
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 109 KB
Volume: 389
Category: Article
ISSN: 0028-0836
DOI: 10.1038/38141

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral mediated cell fusion: Viral fusion

Viral mediated cell fusion: Viral fusion – the making, or breaking, of a tumour?

✍ Vile, R G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

C34, a Membrane Fusion Inhibitor, Blocks

C34, a Membrane Fusion Inhibitor, Blocks HIV Infection of Langerhans Cells and Viral Transmission to T Cells

✍ Sugaya, Makoto; Hartley, Oliver; Root, Michael J; Blauvelt, Andrew 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB

The HIV-1 Vif protein: a paradigm for vi

The HIV-1 Vif protein: a paradigm for viral:cell interactions

✍ R.J. Pomerantz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 105 KB

Relationship between HIV viral load and

Relationship between HIV viral load and Langerhans cells of the cervical epithelium

✍ Gabriel Levi; Joseph Feldman; Susan Holman; Afshin Salarieh; Howard D. Strickler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

SPC3, an anti-HIV peptide construct deri

SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cells

✍ Rym Barbouche; Raymond Miquelis; Jean-Marc Sabatier; Emmanuel Fenouillet 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

SPC 3 is a peptide construct (eight branches of the GPGRAF motif) derived from the consensus sequence present at the apex of the third variable domain of the human immunodeficiency virus (HIV) envelope (Env). It presents a potent anti-HIV activity and is currently tested in phase II clinical trials

Erratum to: Alterations of the B-Cell Re

Erratum to: Alterations of the B-Cell Response by HIV-1 Replication

✍ Xiaoying Shen; Georgia D. Tomaras 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 46 KB